The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine

Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus which causes a lifelong infection. An estimated 5–10 million persons are infected with HTLV-1 worldwide – a number which is likely higher due to lack of reliable epidemiological data. Most infected individuals remain asympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Joshua J., Maksimova, Victoria, Ratner, Lee, Panfil, Amanda R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114509/
https://www.ncbi.nlm.nih.gov/pubmed/35602078
http://dx.doi.org/10.3389/fmicb.2022.897346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114509/
https://www.ncbi.nlm.nih.gov/pubmed/35602078
http://dx.doi.org/10.3389/fmicb.2022.897346

Ejemplares similares